RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Shineway Pharmaceutical Group Stock

China Shineway Pharmaceutical Group Equity 2024

China Shineway Pharmaceutical Group Equity

7.03 B CNY

Ticker

2877.HK

ISIN

KYG2110P1000

WKN

A0DNLW

In 2024, China Shineway Pharmaceutical Group's equity was 7.03 B CNY, a 10.22% increase from the 6.38 B CNY equity in the previous year.

China Shineway Pharmaceutical Group Aktienanalyse

What does China Shineway Pharmaceutical Group do?

China Shineway Pharmaceutical Group Ltd was founded in 1996 and has since become one of the leading Chinese pharmaceutical companies. Based in Beijing, the company offers a wide range of products in various segments, including traditional Chinese medicine, Western medicine, and health products. China Shineway's business model is based on research and development, production, distribution, and marketing of pharmaceutical products. The company strives to advance the development of new drugs and treatment methods by continuously improving its research and development department. The company covers various areas of healthcare, including the manufacturing of remedies for cancer, cardiovascular diseases, orthopedic surgery, and neurology. China Shineway also specializes in the development of herbal medicines for use in traditional Chinese medicine. The company has thus occupied a niche market and is an important provider of natural remedies for various health needs in this niche. Another important aspect of Shineway's business is the production of raw materials for use in other pharmaceutical products. The company has a strong presence in the Chinese market and supplies other companies with pharmaceutical raw materials for drug manufacturing. The company continuously improves its production capacity and implements new technologies for the production of high-quality goods. One of the most well-known products in traditional Chinese medicine at Shineway is Naoxintong. Naoxintong is an herbal medicine used for the treatment of cardiovascular diseases and helps to lower cholesterol levels and blood pressure. The combination of natural plant extracts is unique and has found great demand in China. Another product segment of China Shineway is the business of health products. The company offers high-quality dietary supplements, vitamins, and minerals to improve overall well-being and physical health. The company is committed to ensuring the highest level of quality and safety in all its products. The company also operates a strong international business by exporting its products worldwide. China Shineway has branches in several countries, including Europe, Africa, and Asia, creating access to global markets. Due to the high demand for natural remedies in traditional Chinese medicine, the company has made significant progress in international markets in recent years. China Shineway also has a strong social responsibility and supports numerous charitable and nonprofit organizations in China. The company has launched a donation initiative and distributed medicines and health products for free to those who could not afford them. It is also committed to protecting the environment and invests in environmentally friendly technologies to reduce its carbon footprint. Overall, China Shineway has established itself as an important company in the Chinese pharmaceutical industry and has managed to be successful both internationally and in the domestic market. The company is committed to continuing its commitment to research and development to provide even better drugs and treatment methods in the future. China Shineway Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing China Shineway Pharmaceutical Group's Equity

China Shineway Pharmaceutical Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding China Shineway Pharmaceutical Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating China Shineway Pharmaceutical Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

China Shineway Pharmaceutical Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in China Shineway Pharmaceutical Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about China Shineway Pharmaceutical Group stock

What is the equity of China Shineway Pharmaceutical Group this year?

China Shineway Pharmaceutical Group has equity of 7.03 B CNY this year.

What was the equity of China Shineway Pharmaceutical Group compared to the previous year?

The equity of China Shineway Pharmaceutical Group has increased/decreased by 10.22% increased compared to the previous year.

What impact does a high equity have on investors of China Shineway Pharmaceutical Group?

A high equity is advantageous for investors of China Shineway Pharmaceutical Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of China Shineway Pharmaceutical Group?

A low equity can be a risk for investors of China Shineway Pharmaceutical Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of China Shineway Pharmaceutical Group affect the company?

An increase in equity of China Shineway Pharmaceutical Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of China Shineway Pharmaceutical Group affect the company?

A reduction in equity of China Shineway Pharmaceutical Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of China Shineway Pharmaceutical Group?

Some factors that can affect the equity of China Shineway Pharmaceutical Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of China Shineway Pharmaceutical Group so important for investors?

The equity of China Shineway Pharmaceutical Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can China Shineway Pharmaceutical Group take to change the equity?

To change equity, China Shineway Pharmaceutical Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does China Shineway Pharmaceutical Group pay?

Over the past 12 months, China Shineway Pharmaceutical Group paid a dividend of 0.47 CNY . This corresponds to a dividend yield of about 6.49 %. For the coming 12 months, China Shineway Pharmaceutical Group is expected to pay a dividend of 0.49 CNY.

What is the dividend yield of China Shineway Pharmaceutical Group?

The current dividend yield of China Shineway Pharmaceutical Group is 6.49 %.

When does China Shineway Pharmaceutical Group pay dividends?

China Shineway Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of October, May, June, October.

How secure is the dividend of China Shineway Pharmaceutical Group?

China Shineway Pharmaceutical Group paid dividends every year for the past 22 years.

What is the dividend of China Shineway Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.49 CNY are expected. This corresponds to a dividend yield of 6.81 %.

In which sector is China Shineway Pharmaceutical Group located?

China Shineway Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Shineway Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Shineway Pharmaceutical Group from 9/27/2024 amounting to 0.12 CNY, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did China Shineway Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of China Shineway Pharmaceutical Group in the year 2023?

In the year 2023, China Shineway Pharmaceutical Group distributed 0.383 CNY as dividends.

In which currency does China Shineway Pharmaceutical Group pay out the dividend?

The dividends of China Shineway Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Shineway Pharmaceutical Group

Our stock analysis for China Shineway Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Shineway Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.